Oaktree Acquisition Corp. III Life Sciences (OACC) stock
Close on Nov 17, 2026Market cap $263.53MP/E –Yield –
Earnings
Oaktree Acquisition Corp. III Life Sciences's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Oaktree Acquisition Corp. III Life Sciences's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Guidance
Oaktree Acquisition Corp. III Life Sciences has not given guidance in its releases
Many companies give their outlook only on the conference call or not at all. When Oaktree Acquisition Corp. III Life Sciences puts a forecast in an earnings release, it is listed here with the exact sentence.
Press releases
Releases Oaktree Acquisition Corp. III Life Sciences filed with the SEC as exhibits to Form 8-K or 6-K
See a number that looks wrong?